NASDAQ · Medical - Pharmaceuticals

NEUP (NEUP) Stock

$3.90 +1.30% NASDAQ: NEUP Healthcare

Valuation

MetricValue
Price$3.90
Market Cap$21.08M
P/E Ratio-20.57
P/B Ratio0.88
P/S Ratio-1.62
EPS (TTM)$-0.23
52-Week High$21.40
52-Week Low$3.33
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-3.45%
ROA-2.33%
ROCE-7.14%
Gross Margin-8.33%
Operating Margin-8.33%
Net Margin25.01%
Debt/Equity0.00
Current Ratio3.83

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$24.0M
Operating Profit$-13.0M$-29.0M$-22.0M$-27.0M$-2.0M
Net Profit$-9.0M$-23.0M$-22.0M$-23.0M$-1.0M
EPS$-0.10$-0.13$-0.17$-0.10$-0.23
Op Margin—-10292.0%——-7.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$41.0M$45.0M$19.0M$28.0M$43.0M
Total Liabilities$5.0M$6.0M$5.0M$10.0M$15.0M
Cash$21.0M$23.0M$8.0M$13.0M$22.0M
Borrowings$1.0M$0$0$0$0

Latest News

MRK, NEUP Stocks Drop As Merck Scraps Another Alzheimer’s Drug Trial Under Neuphoria Partnership Stocktwits · Jul 1, 2026 Neuphoria Confirms Business Combination Talks With Scancell MT Newswires · Jun 26, 2026 Neuphoria Responds to the announcement made by London-listed Scancell Holdings plc GlobeNewswire · Jun 26, 2026 Scancell confirms advanced talks over reverse merger with Neuphoria Proactive · Jun 26, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-6.0M$-15.0M$-10.0M$-15.0M$77.0M
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$0$-4.0M$0$5.0M$1.5B
Net Cash Flow$18.0M$3.0M$-15.0M$1.0M$1.6B
Free Cash Flow$-6.0M$-15.0M$-10.0M$-15.0M$77.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield235.80%
Quick Ratio14.31
Interest Coverage—
Return 1Y-53.44%
Return 3Y-89.10%
Return 5Y—

Ownership

Insiders Held7.70%
Institutions Held55.03%
Institutions Float Held59.62%
Institutional HolderSharesReport Date
Lynx1 Capital Management Lp875,3282026-03-31
AdvisorShares Investments, LLC155,3672026-03-31
Shay Capital LLC151,0102026-03-31
Balyasny Asset Management LP142,1832026-03-31
Vanguard Capital Management LLC98,5162026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ALZN $1.35 +0.75% -0.11 $5.14M 0.00%
APRE $0.62 -1.16% -0.47 $4.06M 0.00%
BCDABioCardia, Inc. $0.84 -1.11% -0.83 $4.88M 0.00%
BMRA $1.61 +1.26% -1.09 $4.98M 0.00%
CHEKCheck-Cap Ltd. $1.86 +1.64% -0.43 $10.88M 0.00%

About NEUP

NEUP is led by CEO Spyridon Papapetropoulos, employs 8 people, headquartered in US, publicly traded since 2021.

NEUP stock trades at $3.90 with a market capitalization of $21.08M. The stock is valued at a price-to-earnings (P/E) ratio of -20.57, price-to-book of 0.88, price-to-sales of -1.62. Over the past 52 weeks the stock has ranged between $3.33 and $21.40, and currently trades 81.8% below its 52-week high.

On profitability, NEUP generates a return on equity (ROE) of -3.45%, return on capital employed of -7.14%, an operating margin of -8.33%, a net profit margin of 25.01%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides